Analgesics in Sweden continues to demonstrate robust value growth in 2026, with retail value expected to reach SEK2,066 million thanks to an increase of 2% in current terms, due to strengthening consumer spending and a slightly growing population. The expanding cohort of older adults underpins sustained demand for systemic analgesics, while the surge in e-commerce, led by Apotea and set to account for 17% of value sales, has significantly reshaped consumer access and competitive dynamics. With high concentration, with GSK Consumer Healthcare and McNeil holding significant shares, brand loyalty, broad distribution and established trust remain formidable barriers for new entrants. Attractiveness is bolstered by manufacturers’ innovation in rapid relief and natural pain management solutions to address evolving preferences for convenience and holistic wellbeing. To succeed, brands must prioritise digital engagement, product differentiation, and environmental responsibility, capitalising on demographic shifts and the digital transformation of retail, while adapting to changing consumer health priorities.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Sweden with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Sweden, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Sweden report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Sweden?
- Which are the leading brands in Analgesics in Sweden?
- How are products distributed in Analgesics in Sweden?
- How has the regulatory and operating environment for Analgesics changed in Sweden?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Apotea accelerates online shift as consumers seek convenience and value
Systemic products dominate as chronic pain drives steady demand
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Manufacturers expected to expand natural solutions to retain health-focused buyers
Systemic solutions to maintain their lead as topical products pivot to herbal
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
GSK Consumer Healthcare strengthens its leadership as brand loyalty ensures stability
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retains dominance, although its share gradually erodes
Apotea accelerates e-commerce growth as online pharmacies reshape distribution
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!